Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 3 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Headache, Migraine, and Antiepileptic Drugs During Pregnancy
Medscape· 4 days agoChristoph Diener provides recent updates on headache in children, migraine drugs, and antiepileptic...
Superbug Slayer: New Class of Antibiotics Proves Potent Against Multi-Drug Resistant Bacteria
SciTechDaily· 4 days agoA new class of antibiotics capable of combating multi-drug resistant bacteria and treating bloodstream infections in mice has been unveiled by Uppsala University scientists. Scientists at Uppsala ...
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters· 3 days ago, opens new tab raised its full-year profit forecast on Wednesday on strong demand for its common...
Quest Diagnostics carves out PathAI’s digital pathology lab, plots AI ramp up
FierceBiotech· 3 days agoQuest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 4 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press· 4 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KSAN - KLST San Angelo· 3 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
Clinical Trials: Focus on Quality Over Quantity of Life
Medscape· 2 days agoDr Maurie Markman discusses the need for pragmatic studies focusing on patient quality of life.
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 3 days agoThe letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and...